Zhejiang Shapuaisi Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Shapuaisi Pharmaceutical Co Ltd with three other
companies in this sector in China:
Chongqing Lummy Pharmaceutical Co Ltd
sales of 990.18 million Chinese Renmimbi [US$156.40 million]
of which 98%
was Chemical Manufacturing),
Autobio Diagnostics Co Ltd
(980.22 million Chinese Renmimbi [US$154.83 million]
of which 95%
was In vitro diagnosis), and
Henan Taloph Pharmaceutical Stock Company Limited
(953.31 million Chinese Renmimbi [US$150.57 million]
of which 68%
was Medicine Manufacturing).
Zhejiang Shapuaisi Pharmaceutical Co Ltd reported sales of 978.73 million Chinese Renmimbi (US$154.59 million)
December of 2016.
increase of 6.2%
versus 2015, when the company's sales were 921.67 million Chinese Renmimbi.
Sales at Zhejiang Shapuaisi Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2011, sales have increased a total of 139%).